If you had to describe clinical trial recruitment advertising in one word, what would you choose?
Personally, I’d go with “bland,” although I’d agree if you went with “generic,” “conventional,” or “non-controversial.” As more and more trials begin to actively recruit patients through outreach campaigns and direct advertising, it becomes abundantly clear that advertising for trials is about as conventional and stale as possible.
A conservative approach is understandable. No one wants to risk having their content rejected by IRBs. No one wants patient advocates or regulators concerned about misleading recruitment materials. We live in a heavily-regulated environment, and we should absolutely adhere to the principles of clear and accurate descriptions of clinical research participation.
However, being conservative does not mean that we are forced to be boring and uninspiring. Quite the opposite: We are making demands on patients’ time and privacy when we ask them to enroll in a trial; generic communication is not useful to them in making that decision.
This is why PEPtrials relies upon the best experts out there: the patients and caregivers themselves. We – literally – sit down at the table with them, listen to their journeys, and work with them to identify opportunities to make their experiences better.
We take the depth and breadth of experiences that our patient partners bring to the table, and we combine it with our own expertise: clinical trial communications. We understand the regulatory and scientific environment, we understand visual design, and we know how to write compelling content.
Co-Creation — the interaction between deep patient experience and expert communication strategy – is at the heart of everything we do. The result is content that is authentic, compelling, and useful to patients looking to consider a clinical trial.
Contact us to learn more.